Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.1 | uM | 9 | 156.25 | 71.09 | 78.00 | 119.00 | 0.6555 | 0.1329 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 156.25 | 71.09 | 235.00 | 119.00 | 1.9748 | 3.9963 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 206.00 | 119.00 | 1.7311 | 3.1849 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 159.00 | 119.00 | 1.3361 | 1.9537 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 156.25 | 71.09 | 180.00 | 119.00 | 1.5126 | 2.4902 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 153.00 | 119.00 | 1.2857 | 1.8047 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 236.00 | 119.00 | 1.9832 | 4.0249 |
| BT-20 | Erlotinib | 1 | uM | 9 | 156.25 | 71.09 | 145.00 | 119.00 | 1.2185 | 1.6092 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 71.09 | 171.00 | 119.00 | 1.4370 | 2.2574 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 167.00 | 119.00 | 1.4034 | 2.1553 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 71.09 | 40.00 | 119.00 | 0.3361 | -0.5387 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 107.00 | 119.00 | 0.8992 | 0.7335 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 96.00 | 119.00 | 0.8067 | 0.4981 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 156.25 | 71.09 | 90.00 | 119.00 | 0.7563 | 0.3735 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 169.00 | 119.00 | 1.4202 | 2.2063 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 133.00 | 119.00 | 1.1176 | 1.3229 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 80.00 | 119.00 | 0.6723 | 0.1722 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 141.00 | 119.00 | 1.1849 | 1.5128 |
| BT-20 | Erlotinib | 10 | uM | 9 | 156.25 | 71.09 | 99.00 | 119.00 | 0.8319 | 0.5614 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 97.00 | 119.00 | 0.8151 | 0.5191 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 71.09 | 95.00 | 119.00 | 0.7983 | 0.4771 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 156.25 | 71.09 | 124.00 | 119.00 | 1.0420 | 1.1139 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 156.25 | 71.09 | 167.00 | 119.00 | 1.4034 | 2.1553 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 71.09 | 134.00 | 119.00 | 1.1261 | 1.3464 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 156.25 | 71.09 | 60.00 | 119.00 | 0.5042 | -0.2041 |